Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
40.74
+1.34 (3.40%)
Apr 29, 2025, 3:04 PM CST
SHE:002294 Revenue
In the year 2024, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.01B CNY with 19.22% growth. Shenzhen Salubris Pharmaceuticals had revenue of 1.01B in the quarter ending December 31, 2024, with 11.23% growth.
Revenue
4.01B
Revenue Growth
+19.22%
P/S Ratio
11.40
Revenue / Employee
1.11M
Employees
3,596
Market Cap
45.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.01B | 646.89M | 19.22% |
Dec 31, 2023 | 3.37B | -116.67M | -3.35% |
Jan 1, 2023 | 3.48B | 423.62M | 13.85% |
Jan 1, 2022 | 3.06B | 319.83M | 11.68% |
Dec 31, 2020 | 2.74B | -1.73B | -38.74% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 20.98B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |